Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by juniper88on Jun 28, 2022 8:18am
166 Views
Post# 34786763

RE:RE:OT -- Update on my wife

RE:RE:OT -- Update on my wifeThe scan has to happen before the 3rd cycle.  It is used for a go/nogo decision, whether or not to continue.

Next treatment day would be July 13, but they will do the scan on the 7th of July.  To complicate things my wife's first scan was on May 15 while her 1st treatment was on June 2nd.  So, that means there would have been 2.5 weeks of growth between 1st scan and 1st treatment.  So, getting that 30% shrinkage for a partial response can often take longer than you might think.

qwerty22 wrote:

If asking questions is too intrusive then please don't answer.

So your wife hasn't yet had a scan to confirm any tumour shrinkage? That happens at the end of the 2nd cycle?

 

juniper88 wrote: This post is kind of of topic but still somewhat relevant if you want to know more about late or end stage cancer and how it relates to clinical trials.

As many of you know my wife is battling Ovarian cancer.  She has High Grade ovarian cancer and is negative for all genetic abnormalities that she has been test for. The last time I updated you all was when she was on a Phase I immunotherapy medicine.  Unfortunately that medicine did not help her at all and after the first CT Scan she was taken off the trial.  That is pretty much how all trials work.

While she was on the trial she was hospitalized at Toronto General Hospital because her left lung had collapsed because a tumor had occluded her left main bronchus.  After 7 days of NPO (no food or drink) a bronchoscopy was done to clear out the tumor.  This gave her relieve of about 1.5 weeks until it was occluded again.  She went for another 5 days of NPO and another bronchoscopy to clear it out. She then received 5 days of local radio therapy which seems to have been effective at stopping the growth in this area.

After my wife was taken of the immunotherapy trial we where presented with 3 phase I trials at Karmanos (Detroit),where she is being treated.  However, she would have to wait a month before being able to get on any trial because of the radiotherapy.  We agreed on a trial with the oncologist at Karmanos and returned there at the end of May.

For this or any other trial there is pre-trial screening.  One of the bloodtest that need to be passed was that for bilirubin, and my wife failed that test.  We were back in Windsor already when we got the phone call.  We were told that my wife's bilirubin had come back high and that one of the nurses had noticed that my wife looked jaundiced.  We were told that either we cross the border again and go to the ER or go back to Toronto and go to the ER.  They suspected a bile duct blockage as on a previous CT Scan there were tumors pressing on the bile ducts.  The solution would be to place a stent to keep the bile ducts open. We chose to go back over the border because in Toronto they had not even been willing to place a stent to keep the left main bronchus open, which would be a much easier procedure.

In the ER the appropriate imaging and from there she was admitted to the main hospital  It was confirmed by MRI that her bile ducts where occluded and that a stent would have to be place.  It was the long weekend in the U.S. and the hospital was short staffed.  Our oncologist when way above his duties to make it happen that the stent placement got done.  I have nothing but praise for all involved with my wife's care at Karmanos.  The procedure was very complicated and difficult to do but the surgeon did not give up and he got 2 stents placed.

On June 2nd my wife bloodwork was redone and the bilirubin was back to normal and she received the first cycle of treatment of this new trial. We returned 1 week later in Detroit to do follow up bloodwork and physical assessment (remember these trials are foremost about safety) From the symptoms my wife was now having and the increasing size of her abdomen the oncologist recomended t have an X-Ray done.  From that it was determinded that my wife had a small bowel obstruction which is quite common in late stage ovarian cancer.This had already started before the first cycle treatment.  They wanted to admit her again to the hospital but we have no insurance in the U.S and the stent placement a week and a half before was likely going to be very expensive.  So, I drove her back to the ER at Toronto General that day, and we got her admitted there.  She was there for 12 day hospitalization.  They did something called a NG tube and put her again on NPO. for several days.  Then introduced clear liquids and then full liquids.  Against the doctors medical advice I took her back to Detroit on June 23rd.  She passed all the blood work despite not have eaten much of anything for almost a month (at this point I really want to thank Rusty for all his prayers throughout all of this!!) and she received her 2nd cycle of treatment.

One of the blood test that is done for this particular trial is the CA-125 test.  With some Ovarian cancer patients, like my wife,  it very accucurately predicts how much cancer there is in her body.  That tumor marker had gone down by about 40% after just 1 cycle!!  My wife had tumors had are clear visible and we had noticed that they had become smaller.  I kept saying that it was just our wishful thinking.  But with the CA-125 going down so much, I believe we have some real hope.

 

 

 



<< Previous
Bullboard Posts
Next >>